Rutgers Cancer Institute of New Jersey and its Deputy Director Selected to Lead Global Cancer Grand Challenges Team
A world-class team of researchers assembled and led by Rutgers Cancer Institute of New Jersey and its deputy director and chief scientific officer Eileen White, PhD, have been awarded a $25 million Cancer Grand Challenges grant. The Rutgers-led CANCAN (CANcer Cachexia Action Network) team, joined with Cold Spring Harbor Laboratory and Weill Cornell Medicine, will address the challenge of cancer cachexia – a debilitating wasting condition people often experience in the later stages of their cancer. Cancer Grand Challenges is a global funding platform, co-founded by Cancer Research UK and the National Cancer Institute (NCI) in the US, which supports a community of diverse, global teams to come together, think differently and take on some of cancer’s toughest challenges. Learn more
Treatment of Precancerous Lesions in HIV Individuals Reduces Anal Cancer Risk by Half
A study conducted through the National Cancer Institute -supported AIDS Malignancy Consortium and published in the New England Journal of Medicine reveals that treatment of a precancerous condition known as HSIL (High Grade Squamous Intraepithelial Lesions) of the anus in individuals living with HIV reduces the risk of developing anal cancer in this population by more than half. Mark H. Einstein, MD, MS, FACS, FACOG, a researcher in the Clinical Investigations and Precision Therapeutics Program at Rutgers Cancer Institute of New Jersey, associate dean of clinical research and professor and chair of the Department of Obstetrics, Gynecology, and Reproductive Health at Rutgers New Jersey Medical School, is an author on the work.
The Important Role Advanced Practice Nurses Play in Providing Support for Radiation TherapyInduced Toxicities
Nurse practitioner in the Department of Radiation Oncology at Rutgers Cancer Institute of New Jersey, Dorothy N. Pierce, DNP, NP-C, CRN, CBCN, highlights the role of advanced practice nurses (APNs) in providing supportive care for patients experiencing radiation proctitis, which is painful inflammation of the rectum sometimes caused by radiation therapy. Her work was presented as a poster at the 2022 American Association of Nurse Practitioner (AANP) National Conference in Orlando, Florida that took place last month. Learn more
Rutgers Board of Governors Names Rutgers Cancer Institute’s Dr. Eileen White to Prestigious Professorship
The Rutgers Board of Governors has named Rutgers Cancer Institute of New Jersey Deputy Director Eileen White, PhD, the Board of Governors Professor of Molecular Biology and Biochemistry at the Rutgers School of Arts and Sciences. Rutgers Board of Governors professorships are awarded to faculty members whose academic accomplishments are recognized nationally and globally as being exceptionally outstanding and exemplify the most celebrated and decorated academic scholars at Rutgers. Dr. White is recognized for her contributions to science and leadership in the fields of apoptosis, autophagy and cancer metabolism. Learn more
As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.